Medoo

Medoo is a high-tech enterprise focused on the research, development, production, and sales of advanced endovascular interventional medical devices. The group was founded in 2014 and consists of Shenzhen Medoo Medical Tech. Co., Ltd., Medoo Medical Tech (Hong Kong) Co., Ltd., Jiangsu Medoo Medical Device Technology Co., Ltd., and other companies. Medoo’s partners possess strong technical expertise and have received substantial support from the Shenzhen Science and Technology Innovation Commission. The company currently has six core projects underway in the fields of cardiovascular and peripheral vascular intervention: MeCross CTO high-performance semi-compliant pre-dilation balloon, MeCross NC high-performance non-compliant post-dilation balloon, MeCross PTA peripheral intervention balloon, MePower new anti-slip balloon, restorative balloon, and magnesium alloy degradable stent. Medoo has integrated resources from cardiovascular intervention clinical experts, scientists from the Chinese Academy of Sciences, and endovascular interventional consumables R&D experts. Collaborating with multiple universities and hospitals for industry-university-research cooperation, it has established a world-class R&D and production center in Jiangsu. It has passed the BSI ISO 13485 system certification (MD: 662153) and China GMP certification. Its mainstream products boast excellent performance, have been approved by the EU CE certification and China NPMA certification, and are popular worldwide.